Copyright Reports & Markets. All rights reserved.

Global Fertility Enhancing Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Fertility Enhancing Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Fertility Drugs for Women
      • 1.4.3 Fertility Drugs for Men
      • 1.4.4 OTC Conception Gels/Lubricants
    • 1.5 Market by Application
      • 1.5.1 Global Fertility Enhancing Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Drug Stores
      • 1.5.4 Online
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Fertility Enhancing Treatment Market Size
    • 2.2 Fertility Enhancing Treatment Growth Trends by Regions
      • 2.2.1 Fertility Enhancing Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Fertility Enhancing Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Fertility Enhancing Treatment Market Size by Manufacturers
      • 3.1.1 Global Fertility Enhancing Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Fertility Enhancing Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Fertility Enhancing Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Fertility Enhancing Treatment Key Players Head office and Area Served
    • 3.3 Key Players Fertility Enhancing Treatment Product/Solution/Service
    • 3.4 Date of Enter into Fertility Enhancing Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Fertility Enhancing Treatment Market Size by Type (2014-2019)
    • 4.2 Global Fertility Enhancing Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Fertility Enhancing Treatment Market Size (2014-2019)
    • 5.2 Fertility Enhancing Treatment Key Players in United States
    • 5.3 United States Fertility Enhancing Treatment Market Size by Type
    • 5.4 United States Fertility Enhancing Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Fertility Enhancing Treatment Market Size (2014-2019)
    • 6.2 Fertility Enhancing Treatment Key Players in Europe
    • 6.3 Europe Fertility Enhancing Treatment Market Size by Type
    • 6.4 Europe Fertility Enhancing Treatment Market Size by Application

    7 China

    • 7.1 China Fertility Enhancing Treatment Market Size (2014-2019)
    • 7.2 Fertility Enhancing Treatment Key Players in China
    • 7.3 China Fertility Enhancing Treatment Market Size by Type
    • 7.4 China Fertility Enhancing Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Fertility Enhancing Treatment Market Size (2014-2019)
    • 8.2 Fertility Enhancing Treatment Key Players in Japan
    • 8.3 Japan Fertility Enhancing Treatment Market Size by Type
    • 8.4 Japan Fertility Enhancing Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Fertility Enhancing Treatment Market Size (2014-2019)
    • 9.2 Fertility Enhancing Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Fertility Enhancing Treatment Market Size by Type
    • 9.4 Southeast Asia Fertility Enhancing Treatment Market Size by Application

    10 India

    • 10.1 India Fertility Enhancing Treatment Market Size (2014-2019)
    • 10.2 Fertility Enhancing Treatment Key Players in India
    • 10.3 India Fertility Enhancing Treatment Market Size by Type
    • 10.4 India Fertility Enhancing Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Fertility Enhancing Treatment Market Size (2014-2019)
    • 11.2 Fertility Enhancing Treatment Key Players in Central & South America
    • 11.3 Central & South America Fertility Enhancing Treatment Market Size by Type
    • 11.4 Central & South America Fertility Enhancing Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Merck
      • 12.1.1 Merck Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Fertility Enhancing Treatment Introduction
      • 12.1.4 Merck Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.1.5 Merck Recent Development
    • 12.2 Ferring
      • 12.2.1 Ferring Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Fertility Enhancing Treatment Introduction
      • 12.2.4 Ferring Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.2.5 Ferring Recent Development
    • 12.3 MSD
      • 12.3.1 MSD Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Fertility Enhancing Treatment Introduction
      • 12.3.4 MSD Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.3.5 MSD Recent Development
    • 12.4 LIVZON
      • 12.4.1 LIVZON Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Fertility Enhancing Treatment Introduction
      • 12.4.4 LIVZON Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.4.5 LIVZON Recent Development
    • 12.5 Abbott
      • 12.5.1 Abbott Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Fertility Enhancing Treatment Introduction
      • 12.5.4 Abbott Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.5.5 Abbott Recent Development
    • 12.6 Bayer Zydus Pharma
      • 12.6.1 Bayer Zydus Pharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Fertility Enhancing Treatment Introduction
      • 12.6.4 Bayer Zydus Pharma Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.6.5 Bayer Zydus Pharma Recent Development
    • 12.7 Church＆Dwight
      • 12.7.1 Church＆Dwight Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Fertility Enhancing Treatment Introduction
      • 12.7.4 Church＆Dwight Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.7.5 Church＆Dwight Recent Development
    • 12.8 SASMAR
      • 12.8.1 SASMAR Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Fertility Enhancing Treatment Introduction
      • 12.8.4 SASMAR Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.8.5 SASMAR Recent Development
    • 12.9 BioFilm,Inc
      • 12.9.1 BioFilm,Inc Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Fertility Enhancing Treatment Introduction
      • 12.9.4 BioFilm,Inc Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.9.5 BioFilm,Inc Recent Development
    • 12.10 FAIRHAVEN HEALTH
      • 12.10.1 FAIRHAVEN HEALTH Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Fertility Enhancing Treatment Introduction
      • 12.10.4 FAIRHAVEN HEALTH Revenue in Fertility Enhancing Treatment Business (2014-2019)
      • 12.10.5 FAIRHAVEN HEALTH Recent Development
    • 12.11 The YES YES Company

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
      The classification of Fertility Enhancing Treatment includes Fertility Drugs for Women, Fertility Drugs for Men and OTC Conception Gels/Lubricants, and the proportion of Fertility Drugs for Women in 2017 is about 88%.
      North America and Europe are the two largest consumption place, with a similar consumption market share nearly 33% in 2017. Following North America and Europe, China is the third consumption place with the consumption market share of 9.4%.
      In 2018, the global Fertility Enhancing Treatment market size was 4380 million US$ and it is expected to reach 6260 million US$ by the end of 2025, with a CAGR of 5.2% during 2019-2025.

      This report focuses on the global Fertility Enhancing Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fertility Enhancing Treatment development in United States, Europe and China.

      The key players covered in this study
      Merck
      Ferring
      MSD
      LIVZON
      Abbott
      Bayer Zydus Pharma
      Church＆Dwight
      SASMAR
      BioFilm,Inc
      FAIRHAVEN HEALTH
      The YES YES Company

      Market segment by Type, the product can be split into
      Fertility Drugs for Women
      Fertility Drugs for Men
      OTC Conception Gels/Lubricants

      Market segment by Application, split into
      Hospitals
      Drug Stores
      Online

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Fertility Enhancing Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Fertility Enhancing Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Fertility Enhancing Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now